Literature DB >> 16572206

HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation.

J Bergeron, E Clappier, B Cauwelier, N Dastugue, C Millien, E Delabesse, K Beldjord, F Speleman, J Soulier, E Macintyre, V Asnafi.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16572206     DOI： 10.1038/sj.leu.2404187

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Takaomi Sanda; Wenxue Ma; Jianhua Zhang; Ruta Grebliunaite; Suzanne Dahlberg; Donna Neuberg; Alexei Protopopov; Stuart S Winter; Richard S Larson; Michael J Borowitz; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Catriona Jamieson; Stephen E Sallan; A Thomas Look
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

2.  HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?

Authors:  Jules Pp Meijerink; Kirsten Canté-Barrett; Eric Vroegindeweij; Rob Pieters
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

Review 3.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

4.  Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223.

Authors:  Sabina Chiaretti; Monica Messina; Simona Tavolaro; Giuseppe Zardo; Loredana Elia; Antonella Vitale; Alessandro Fatica; Paolo Gorello; Alfonso Piciocchi; Gina Scappucci; Irene Bozzoni; Claudio Fozza; Anna Candoni; Anna Guarini; Robin Foà
Journal:  Haematologica       Date:  2010-04-23       Impact factor: 9.941

5.  Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.

Authors:  David Caudell; Zhenhua Zhang; Yang Jo Chung; Peter D Aplan
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

6.  Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.

Authors:  Paolo Gorello; Roberta La Starza; Emanuela Varasano; Sabina Chiaretti; Loredana Elia; Valentina Pierini; Gianluca Barba; Lucia Brandimarte; Barbara Crescenzi; Antonella Vitale; Monica Messina; Sara Grammatico; Marco Mancini; Caterina Matteucci; Antonella Bardi; Anna Guarini; Massimo Fabrizio Martelli; Robin Foà; Cristina Mecucci
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

7.  Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.

Authors:  Linda Zuurbier; Alejandro Gutierrez; Charles G Mullighan; Kirsten Canté-Barrett; A Olivier Gevaert; Johan de Rooi; Yunlei Li; Willem K Smits; Jessica G C A M Buijs-Gladdines; Edwin Sonneveld; A Thomas Look; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

8.  RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.

Authors:  Ali Sakhdari; Beenu Thakral; Sanam Loghavi; Rashmi Kanagal-Shamanna; C Cameron Yin; Zhuang Zuo; Mark J Routbort; Rajyalakshmi Luthra; L Jeffrey Medeiros; Sa A Wang; Keyur P Patel; Chi Young Ok
Journal:  Cancer Med       Date:  2019-12-05       Impact factor: 4.452

Review 9.  T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.

Authors:  Valentina Bardelli; Silvia Arniani; Valentina Pierini; Danika Di Giacomo; Tiziana Pierini; Paolo Gorello; Cristina Mecucci; Roberta La Starza
Journal:  Genes (Basel)       Date:  2021-07-23       Impact factor: 4.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.